Mengru Bai

440 total citations
23 papers, 321 citations indexed

About

Mengru Bai is a scholar working on Oncology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Mengru Bai has authored 23 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Clinical Biochemistry and 6 papers in Molecular Biology. Recurrent topics in Mengru Bai's work include Drug Transport and Resistance Mechanisms (10 papers), Metabolism and Genetic Disorders (7 papers) and Liver Disease Diagnosis and Treatment (4 papers). Mengru Bai is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Metabolism and Genetic Disorders (7 papers) and Liver Disease Diagnosis and Treatment (4 papers). Mengru Bai collaborates with scholars based in China. Mengru Bai's co-authors include Huidi Jiang, Hui Zhou, Zhiyuan Ma, Dongli Sun, Su Zeng, Caihong Zheng, Ting Jiang, Liping Li, Mingyang Chen and Nengming Lin and has published in prestigious journals such as Nature Communications, Free Radical Biology and Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mengru Bai

21 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengru Bai China 13 102 86 72 52 38 23 321
Eva Doleželová Czechia 16 137 1.3× 109 1.3× 69 1.0× 69 1.3× 10 0.3× 26 484
Ryoichi Yano Japan 11 108 1.1× 115 1.3× 24 0.3× 20 0.4× 28 0.7× 31 376
Marina Rousseau Canada 11 45 0.4× 79 0.9× 58 0.8× 53 1.0× 34 0.9× 15 341
Kazushige Takahashi Japan 10 175 1.7× 110 1.3× 16 0.2× 119 2.3× 31 0.8× 26 400
Verena Häfner Germany 6 23 0.2× 79 0.9× 36 0.5× 38 0.7× 28 0.7× 8 316
Zeinab Karimi Iran 12 57 0.6× 68 0.8× 26 0.4× 20 0.4× 17 0.4× 45 382
Xiaozhou Yao United States 8 188 1.8× 165 1.9× 84 1.2× 32 0.6× 24 0.6× 12 382
Nataša Karas Kuželički Slovenia 14 70 0.7× 156 1.8× 21 0.3× 150 2.9× 40 1.1× 42 489
Habib Hasannejad Japan 6 213 2.1× 85 1.0× 13 0.2× 120 2.3× 41 1.1× 7 437
Huan Zheng China 13 52 0.5× 127 1.5× 40 0.6× 8 0.2× 15 0.4× 31 354

Countries citing papers authored by Mengru Bai

Since Specialization
Citations

This map shows the geographic impact of Mengru Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengru Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengru Bai more than expected).

Fields of papers citing papers by Mengru Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengru Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengru Bai. The network helps show where Mengru Bai may publish in the future.

Co-authorship network of co-authors of Mengru Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Mengru Bai. A scholar is included among the top collaborators of Mengru Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengru Bai. Mengru Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Mingyang, Hui Chang, Jun Luo, et al.. (2025). SLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters. Nature Communications. 16(1). 1181–1181. 5 indexed citations
2.
Chen, Mingyang, Mengru Bai, Dongli Sun, et al.. (2025). Upregulation of hepatic flavin-containing monooxygenase 3 by increased corticosterone via glucocorticoid receptor contributes to gestational diabetes mellitus. Drug Metabolism and Disposition. 53(9). 100133–100133.
3.
Chen, Xiaojing, Yue Gao, Jun Luo, et al.. (2024). Unconjugated bilirubin promotes uric acid restoration by activating hepatic AMPK pathway. Free Radical Biology and Medicine. 224. 644–659. 6 indexed citations
4.
5.
6.
Chen, Mingyang, Mengru Bai, Jun Luo, et al.. (2022). Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice. Toxicology Letters. 363. 1–10. 15 indexed citations
8.
Zhou, Ying, Jianfeng Zheng, Mengru Bai, Yuzhen Gao, & Nengming Lin. (2022). Effect of Pyroptosis-Related Genes on the Prognosis of Breast Cancer. Frontiers in Oncology. 12. 948169–948169. 11 indexed citations
9.
Bai, Mengru, Mingyang Chen, Li Ping, et al.. (2022). Up‐regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy. British Journal of Pharmacology. 179(17). 4440–4456. 15 indexed citations
10.
Ping, Li, Yuqing Wang, Jun Luo, et al.. (2020). Downregulation of OCTN2 by cytokines plays an important role in the progression of inflammatory bowel disease. Biochemical Pharmacology. 178. 114115–114115. 18 indexed citations
11.
Jiang, Ting, Mengru Bai, Ping Li, et al.. (2019). Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis. Toxicology Letters. 316. 183–193. 23 indexed citations
12.
Bai, Mengru, Ying‐Chun Chen, Mingyang Chen, et al.. (2019). Maternal Plasma l-Carnitine Reduction During Pregnancy Is Mainly Attributed to OCTN2-Mediated Placental Uptake and Does Not Result in Maternal Hepatic Fatty Acid β-Oxidation Decline. Drug Metabolism and Disposition. 47(6). 582–591. 10 indexed citations
13.
Bai, Mengru, Cui Li, Zhiyuan Ma, et al.. (2019). Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine. Antimicrobial Agents and Chemotherapy. 63(8). 17 indexed citations
14.
15.
Bai, Mengru, Zhiyuan Ma, Dongli Sun, et al.. (2017). Multiple drug transporters mediate the placental transport of sulpiride. Archives of Toxicology. 91(12). 3873–3884. 30 indexed citations
16.
Ma, Zhiyuan, Xi Yang, Ting Jiang, et al.. (2017). Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir. Drug Metabolism and Disposition. 45(3). 269–278. 32 indexed citations
17.
Ma, Zhiyuan, Xi Yang, Mengru Bai, et al.. (2017). The predominant role of human concentrative nucleoside transporter 3 in the placental transfer of EK, an antiviral drug. Drug Metabolism and Pharmacokinetics. 32(1). S104–S105. 2 indexed citations
18.
Li, Liping, et al.. (2017). Multiple organic cation transporters contribute to the renal transport of sulpiride. Biopharmaceutics & Drug Disposition. 38(9). 526–534. 19 indexed citations
19.
Bai, Mengru, et al.. (2016). [Expression and regulation of drug transporters in placenta].. PubMed. 51(6). 879–85. 1 indexed citations
20.
Li, Liping, Siyuan Sun, Feifeng Song, et al.. (2015). Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3. Xenobiotica. 46(2). 175–183. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026